Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term:
2002 / 11
PHARMAC documents that matched your search:
More people to access anaemia drug
(2 pages, 34 KB)
2002/11/25
The number of people able to have subsidised access to a treatment for anaemia associated with kidney failure is set to nearly double following an agreement between PHARMAC and Roche Products.
PHARMAC delivers better health in 2002
(7 pages, 113 KB)
2002/11/13
Almost 40,000 New Zealanders have access to better health as a result of pharmaceutical funding decisions made in the 2002 financial year. PHARMAC’s 2002 Annual Review, published today, highlights that new or or expanded access was provided to 24 different pharmaceuticals and produced savings worth more than $36 million in the 2002 financial year.
Annual Review 2002
(28 pages, 1059 KB)
2002/11/04
Major PHARMAC achievements in 2001-02 were: Providing new or wider access to 24 subsidised treatments, including those for raised cholesterol, multiple sclerosis, schizophrenia, epilepsy, arthritis and hay fever under cost-neutral and/or financially sustainable arrangements. Containing pharmaceutical expenditure growth by successfully negotiating savings worth approximately $36.8 million...
NZ in top rung of nations funding new cancer drug
(2 pages, 35 KB)
2002/11/04
New Zealand will become one of the first countries in the world to fund imatinib mesylate (Glivec) as a first line treatment for chronic myeloid leukaemia, should the new therapy be approved for this use by the Ministry of Health. PHARMAC has agreed to fund Glivec for all patients for whom it is currently approved for use.
2002-11 PTAC Minutes (Metronidazole Gel)
(2 pages, 8 KB)
2002/11/01
The Committee first considered an application from St Ives Medical to list the Orion brand of metronidazole gel 0.5%, 10g on the Pharmaceutical Schedule at it s 22…
